Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey

Clinical and Translational Allergy

Volumn 3, Issue 1, 2013, Pages 1-9

  Small, Mark ^a   Piercy, James ^a   Demoly, Pascal ^b   Marsden, Helen ^c  

^a ADELPHI REAL WORLD   (United Kingdom)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Intra nasal steroids; Seasonal allergic rhinitis; Symptom free days

Indexed keywords

FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; MOMETASONE FUROATE;

ADULT; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; FRANCE; GENERAL PRACTITIONER; GERMANY; HUMAN; IMMUNOLOGIST; MAJOR CLINICAL STUDY; MALE; MINI RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; PITTSBURGH SLEEP QUALITY INDEX; POLLEN ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SPAIN; SYMPTOM; TELEPHONE INTERVIEW;

EID: 85006084824     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/2045-7022-3-33     Document Type: Article

References (30)

1. Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004, 24: 758-764. 10.1183/09031936.04.00013904.
2. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC: A survey of the burden of AR in Europe. Allergy. 2007, 62 (Suppl 85): 17-25.
3. Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, Yelin EH: The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol. 2001, 54: 610-618. 10.1016/S0895-4356(00)00349-8.
4. Vuurman EF, van Veggel LM, Sanders RL, Muntjewerff ND, O’Hanlon JF: Effects of semprex-D and diphenhydramine on learning in young adults with SAR. Ann Allergy Asthma Immunol. 1996, 76: 247-252. 10.1016/S1081-1206(10)63435-7.
5. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A: SAR is associated with detrimental effect on examination performance in UK teenagers. J Allergy Clin Immunol. 2007, 120: 381-387. 10.1016/j.jaci.2007.03.034.
6. Meltzer EO, Nathan RA, Selner JC, Storms W: QoL and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol. 1997, 99: S815-S819. 10.1016/S0091-6749(97)80041-3.
7. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F: QoL in AR and asthma. A population-based study of young adults. Am J Respir Crit Care Med. 2000, 162: 1391-1396. 10.1164/ajrccm.162.4.9912033.
8. van Cauwenberge P, Van Hoecke H, Kardos P, Price D, Waserman S: Current burden of AR among primary care practitioners and its impact on patient management. Prim Care Respir J. 2009, 18: 27-33. 10.3132/pcrj.2008.00042.
9. Virchow JC, Kay S, Demoly P, Mullol J, Canonica W, Higgins V: Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients - an observational, cross sectional study in four countries in Europe. J Med Econ. 2011, 14: 305-314. 10.3111/13696998.2011.576039.
10. Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E: Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Curr Med Res Opin. 2009, 25: 1393-1401. 10.1185/03007990902890512.
11. Bielory L: Allergic Conjunctivitis and the impact of Allergic Rhinitis. Curr Allergy Asthma Rep. 2010, 10: 122-134. 10.1007/s11882-010-0087-1.
12. DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA: The efficacy of intranasal Fluticasone Propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy and Asthma Proc. 2003, 24: 331-337.
13. Bartra J, Mullol J, Montoro J, Jauregui I, del Cuvillo A, Davila I, Ferrer M, Sastre J, Valero A: Effect of bilsatime upon the ocular symptoms of allergic rhinoconjunctivitis. J Investig Allergol Clin Immunol. 2011, 21 (Suppl 3): 24-33.
14. Lightman S, Scadding GK: Should intranasal corticosteroids be used for the treatment of ocular symptoms of Allergic Rhinoconjunctivitis? A review of the efficacy and safety profile. Int Arch Allergy Immunol. 2012, 158: 317-325. 10.1159/000333100.
15. Hellings PW, Dobbels F, Denhaerynck K, Piessens M, Ceuppens JL, De Geest S: Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transl Allergy. 2012, 2: 9-10.1186/2045-7022-2-9.
16. Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH, Lanier BQ, Penna P and the American Academy of Otolaryngic Allergy Working Group on Allergic Rhinitis: Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance and satisfaction. Otolaryngol Head Neck Surg. 2007, 136: S107-S124. 10.1016/j.otohns.2007.02.031.
17. Given JT, Cheema AS, Dreykluft T: Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults. Am J Rhinol Allergy. 2010, 24: 444-450. 10.2500/ajra.2010.24.3534.
18. Meltzer EO, Munafo DA, Chung W, Gopalan G, Varghese ST: Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol. 2010, 105: 65-74. 10.1016/j.anai.2010.04.020.
19. Scichilone N, Arrigo R, Paterno A, Santagata R, Impellitteri S, Braido F, Baiardini I, Battaglia S, Canonica GW, Bellia V: The effect of intranasal corticosteroids on asthma control and quality of life in allergic rhinitis with mild asthma. J Asthma. 2011, 48: 41-47. 10.3109/02770903.2010.528821.
20. Rodrigo GJ, Neffen H: Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy. 2011, 41: 160-170. 10.1111/j.1365-2222.2010.03654.x.
21. Ciprandi G, Canonica WG, Grosclaude M, Ostinelli J, Brazzola GG, Bousquet J: Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy. 2002, 57: 586-591. 10.1034/j.1398-9995.2002.03228.x.
22. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, Van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet L-P, Bousquet P-J, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, Van Wijk RG, Kalayci O, Kaliner MA, Kim Y-Y, Kowalski ML: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008, 63 (suppl 86): 8-160.
23. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN: Development and calibration of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy. 2000, 30: 132-140. 10.1046/j.1365-2222.2000.00668.x.
24. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research. 1989, 28: 193-213. 10.1016/0165-1781(89)90047-4.
25. Reilly MC, Tanner A, Meltzer EO: Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest. 1996, 11: 278-288. 10.2165/00044011-199611050-00004.
26. Scadding G, Williams A: The burden of allergic rhinitis as reported by UK patients compared with their doctors. Rhinology. 2008, 46: 99-106.
27. Villa E, Magnoni MS, Micheli D, Canonica GW: A review of the use of fluticasone furoate since its launch. Expert Opin Pharmacother. 2011, 12: 2107-2117. 10.1517/14656566.2011.600688.
28. Okubo K, Nakashima M, Miyake N, Komatsubara M, Okuda M: Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. Allergy Asthma Proc. 2009, 30: 84-94. 10.2500/aap.2009.30.3182.
29. Meltzer EO, Andrews C, Journeay GE, Lim J, Prillaman BA, Garris C, Philpot E: Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study. Ann Allergy Asthma Immunol. 2010, 104: 331-338. 10.1016/j.anai.2010.02.010.
30. Garris C, Shah M, D'Souza A, Stanford R: Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: Retrospective cohort analysis of pharmacy claims data. Clin Drug Invest. 2009, 29: 515-526. 10.2165/00044011-200929080-00002.